Literature DB >> 4070332

Different effects of apomorphine on climbing behavior and locomotor activity in three strains of mice.

S Cabib, S Puglisi-Allegra.   

Abstract

Apomorphine (0.1, 0.25, 0.5, 1, 3 mg/kg, SC), induces a dose-dependent reduction of locomotor activity in DBA/2(DBA) and BALB/c(BALB) mice, while it enhances locomotor activity in a biphasic way in C57BL/6(C57) mice. On the other hand, apomorphine is ineffective in modifying climbing behavior in DBA mice while it increases climbing behavior in C57 and BALB mice. The results, taken together, suggest that these are two different behaviors, possibly controlled by different dopaminergic mechanisms depending on the genetic makeup.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4070332     DOI: 10.1016/0091-3057(85)90418-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse.

Authors:  S Cabib; C Castellano; V Cestari; U Filibeck; S Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Appearance of a stereotyped apomorphine-induced climbing in unresponsive DBA2 mice after subchronic manipulations of brain dopamine transmission.

Authors:  D Duterte-Boucher; J Costentin
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish.

Authors:  T D Irons; P E Kelly; D L Hunter; R C Macphail; S Padilla
Journal:  Pharmacol Biochem Behav       Date:  2012-12-28       Impact factor: 3.533

4.  Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.

Authors:  S M Fleming; J Salcedo; C B Hutson; E Rockenstein; E Masliah; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2006-08-23       Impact factor: 3.590

5.  Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia.

Authors:  Byron K Y Bitanihirwe; Daria Peleg-Raibstein; Forouhar Mouttet; Joram Feldon; Urs Meyer
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

6.  Differential sensitivity to acute administration of Ritalin, apomorphine, SCH 23390, but not raclopride in mice selectively bred for hyperactive wheel-running behavior.

Authors:  J S Rhodes; T Garland
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

7.  Genotype-dependent modulation of LY 171555-induced defensive behavior in the mouse.

Authors:  S Cabib; S Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Verticalization of behavior elicited by dopaminergic mobilization is qualitatively different between C57BL/6J and DBA/2J mice.

Authors:  E Tirelli; J M Witkin
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

9.  SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function.

Authors:  Mihyun Bae; Junyeop Daniel Roh; Youjoung Kim; Seong Soon Kim; Hye Min Han; Esther Yang; Hyojin Kang; Suho Lee; Jin Yong Kim; Ryeonghwa Kang; Hwajin Jung; Taesun Yoo; Hyosang Kim; Doyoun Kim; Heejeong Oh; Sungwook Han; Dayeon Kim; Jinju Han; Yong Chul Bae; Hyun Kim; Sunjoo Ahn; Andrew M Chan; Daeyoup Lee; Jin Woo Kim; Eunjoon Kim
Journal:  EMBO Mol Med       Date:  2021-01-11       Impact factor: 12.137

10.  EZH2 Influences mdDA Neuronal Differentiation, Maintenance and Survival.

Authors:  Iris Wever; Lars von Oerthel; Cindy M R J Wagemans; Marten P Smidt
Journal:  Front Mol Neurosci       Date:  2019-01-17       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.